Search

Search Constraints

You searched for: Author/Creator Bohnert, Tonika

Search Results

1. Optimization of novel reversible Bruton's tyrosine kinase inhibitors identified using Tethering-fragment-based screens. Issue 13 (1st July 2019)

2. Utilizing structure based drug design and metabolic soft spot identification to optimize the in vitro potency and in vivo pharmacokinetic properties leading to the discovery of novel reversible Bruton's tyrosine kinase inhibitors. (15th August 2021)

3. Discovery of novel pyrazole-containing benzamides as potent RORγ inverse agonists. Issue 15 (1st August 2015)

4. Discovery of biaryl carboxylamides as potent RORγ inverse agonists. Issue 15 (1st August 2015)

5. Translational pharmacokinetic-pharmacodynamic analysis in the pharmaceutical industry: an IQ Consortium PK-PD Discussion Group perspective. Issue 10 (October 2017)

6. Discovery of novel pyrazole-containing benzamides as potent RORγ inverse agonists. Issue 15 (1st August 2015)

7. Discovery of biaryl carboxylamides as potent RORγ inverse agonists. Issue 15 (1st August 2015)

9. Discovery of structural diverse reversible BTK inhibitors utilized to develop a novel in vivo CD69 and CD86 PK/PD mouse model. (15th January 2023)